Document:

Letter Agreement by and between Gary J. Konnie

 Exhibit 10.2 
  
 November 11, 2004 
  
 Personal and Confidential 
  
 Mr. Gary J. Konnie 
 1914 W. Gray #304 
 Houston, TX 77019 
  
 Dear Gary, 
  
 I am pleased to formalize this
offer of employment. As we discussed, the terms and conditions of the offer are as follows: 
  

			
	Start Date	 	On or about November 11, 2004
		
	Position	 	Vice President – Human Resources (reporting to the President and CEO)
		
	Base Salary	 	$175,000 payable on a semi-monthly basis.
		
	Annual Bonus	 	Your target and maximum bonus opportunities are 35% and 70%, respectively, of your annual base salary. The annual bonus is based on overall company and individual performance and is paid in
the year after it is earned, subject to Board approval. You will be eligible to receive a prorated annual bonus for 2004, including the time spent as a consultant.
		
	Restricted Stock	 	You will receive 25,000 shares of U.S. Concrete, Inc. restricted stock. The shares will vest in four equal installments over four years (6,250 shares vesting per year) on November 1 of 2005,
2006, 2007 and 2008. Future share awards will be consistent with awards granted similarly situated officers as approved by the Board of Directors.
		
	Benefits	 	You will be eligible to participate in all health and welfare benefit programs available to similarly situated U.S. Concrete team members. A copy of the summary plan descriptions for these
programs will be sent to you shortly. Also, you will be eligible to participate in U.S. Concrete’s 401(k) and Employee Stock Purchase Plan.

			
	Vacation	  	Beginning on your start date you will be eligible for four weeks of vacation from then until December 31, 2005. Beginning January 1, 2006, your annual vacation eligibility will be four
weeks.
		
	Severance Pay	  	Should you be terminated involuntarily without cause, you will be eligible to receive a severance payment equal to your annual base pay, your annual target bonus and vesting of any restricted
stock which vests on a time only basis. Receipt of severance pay is contingent upon the signing of an agreement and release.
		
	Change of Control	  	Upon a change of control of U.S. Concrete (as defined for similarly situated corporate officers), any restricted stock which vests on a time only basis shall immediately vest. Should you be
terminated involuntarily without cause within one year of a change of control, you will be eligible to receive a severance payment equal to your annual base pay and your annual target bonus. Receipt of severance pay is contingent upon the signing of
an agreement and release.

  
 As you are aware, federal law requires
us to verify your eligibility for employment in the United States. We will review the customary I-9 documentation at your time of hire. Please be advised that nothing in this term sheet is intended to create any contract of employment. If you accept
employment with U.S. Concrete, your employment will be on an at-will basis, which means that either you or U.S. Concrete may terminate the employment relationship at any time with or without notice and with or without cause. 
  
 Gary, we are extremely pleased to have the opportunity to work with an individual of your
capability and reputation. Please acknowledge your acceptance of this offer by signing in the space below and returning the letter to me. If you have any questions, do not hesitate to give me a call. 
  
 Sincerely, 
  

	
	 /s/ Eugene Martineau

	Eugene Martineau
	President and CEO
	U.S. Concrete, Inc.

  

	
	Agreed and Accepted
	
	 /s/ Gary J. Konnie

	Date 11/4/04Letter Agreement by and between Wally H. Johnson

 Exhibit 10.3 
  
 November 11, 2004 
  
 Personal and Confidential 
  
 Mr. Wallace H. Johnson 
 105 Claremont Dr. 
 Naperville, IL 60540 
  
 Dear Wally, 
  
 I am pleased to formalize this
offer of employment. As we discussed, the terms and conditions of the offer are as follows: 
  

			
	 Start Date
	 	On or about November 22, 2004
		
	 Position
	 	Vice President – Marketing and Sales (reporting to the Chief Operating Officer)
		
	 Base Salary
	 	$175,000 payable on a semi-monthly basis.
		
	 Annual Bonus
	 	Your target and maximum bonus opportunities are 35% and 70%, respectively, of your annual base salary. The annual bonus is based on overall company and individual performance and is paid in
the year after it is earned, subject to Board approval. You will be eligible to receive a prorated annual bonus for 2004.
		
	 Restricted Stock
	 	You will receive 25,000 shares of U.S. Concrete, Inc. restricted stock. The shares will vest in four equal installments over four years (6,250 shares vesting per year) on November 1 of 2005,
2006, 2007 and 2008. Future share awards will be consistent with awards granted similarly situated officers as approved by the Board of Directors.
		
	 Benefits
	 	You will be eligible to participate in all health and welfare benefit programs available to similarly situated U.S. Concrete team members. A copy of the summary plan descriptions for these
programs will be sent to you shortly. Also, you will be eligible to participate in U.S. Concrete’s 401(k) and Employee Stock Purchase Plan.
		
	 Vacation
	 	Beginning on January 1, 2005 you will be eligible for four weeks of vacation.
		
	 Relocation
	 	We agree to reimburse you for the transport of your household goods (with a carrier approved in

			
	 	 	advance by U.S. Concrete), usual and customary closing costs on the sale of your current residence and the purchase of a new residence within one year of your start date, and usual and
customary costs for: 1) 60 days of temporary living expenses; 2) a house hunting trip for you and your spouse; and 3) the final relocation trip.
		
	 Severance Pay
	 	Should you be terminated involuntarily without cause, you will be eligible to receive a severance payment equal to your annual base pay, your annual target bonus and vesting of any restricted
stock which vests on a time only basis. Receipt of severance pay in is contingent upon the signing of an agreement and release.
		
	 Change of Control
	 	Upon a change of control of U.S. Concrete (as defined for similarly situated corporate officers), any restricted stock which vests on a time only basis shall immediately vest. Should you be
terminated involuntarily without cause within one year of a change of control, you will be eligible to receive a severance payment equal to your annual base pay and your annual target bonus. Receipt of severance pay is contingent upon the signing of
an agreement and release.

  
 As you are aware, federal law requires
us to verify your eligibility for employment in the United States. We will review the customary I-9 documentation at your time of hire. Please be advised that nothing in this term sheet is intended to create any contract of employment. If you accept
employment with U.S. Concrete, your employment will be on an at-will basis, which means that either you or U.S. Concrete may terminate the employment relationship at any time with or without notice and with or without cause. 
  
 Wally, we are extremely pleased to have the opportunity to work with an individual of your
capability and reputation. Please acknowledge your acceptance of this offer by signing in the space below and returning the letter to me. If you have any questions, do not hesitate to give Gary Konnie or me a call. 
  

	
	Sincerely,
	 /s/ Michael Harlan

	Michael Harlan
	Chief Operating Officer
	U.S. Concrete, Inc.

  

	
	Agreed and Accepted
	
	 /s/ Wallace H. Johnson

	 Date 11/11/04Form of Stock Purchase Agreement

 Exhibit 4.1 
  
 STOCK PURCHASE AGREEMENT 
  
 November 8, 2004 
  
 The Sands Regent 
 345 North Arlington Avenue

 Reno, Nevada 89501 
  
 The undersigned (the “Investor”), hereby confirms its agreement with you as follows: 
  
 1. This Stock Purchase Agreement (the “Agreement”) is made as of the date set forth above between The Sands Regent,
a Nevada corporation (the “Company”) and the Investor. 
  
 2.
The Company has authorized the sale and issuance of up to 1,120,000 shares (the “Shares”) of common stock of the Company, $.10 par value per share (the “Common Stock”), to certain investors in a private
placement (the “Offering”). In consideration for the purchase of aforementioned Shares, the Investor will also receive from the Company a Warrant giving the Investor, upon the exercise thereof, up to
             Shares of Common Stock (the “Warrant Shares”) of the Company (the “Warrant”). The Shares, Warrant Shares and the Warrant are referred
to collectively herein as the “Securities”. 
  
 3. The
Company and the Investor agree that the Investor will purchase from the Company and the Company will issue and sell to the Investor (A)              Shares at a purchase price of
$8.25 per Share (the “Per Share Purchase Price”) and (B) the Warrant, for an aggregate purchase price of
$                    , pursuant to the Terms and Conditions for Purchase of Shares attached hereto as Annex I and incorporated herein by this
reference as if fully set forth herein. Unless otherwise requested by the Investor in Exhibit A, certificates representing the Shares purchased by the Investor will be registered in the Investor’s name and address as set forth below.

  
 4. The Investor represents that, except as set forth below, (a) it has
had no position, office or other material relationship within the past three years with the Company or its affiliates, (b) neither it, nor any group of which it is a member or to which it is related, beneficially owns (including the right to acquire
or vote) any securities of the Company and (c) it has no direct or indirect affiliation or association with any National Association of Securities Dealers, Inc. (“NASD”) member. Exceptions: 
  

 (If no exceptions, write
“none.” If left blank, response will be deemed to be “none.”) 

 IN WITNESS WHEREOF, the parties have executed this Security Purchase Agreement as of the date first written above.

  

	
	NAME OF INVESTING ENTITY
	  
  

	
	 By:

	             Name:

	             Title:

	
	 Investment Amount: $

	
	 Tax ID No.:

	
	ADDRESS FOR NOTICE
	
	 c/o:

	
	 Street:

	
	 City/State/Zip:

	
	 Attention:

	
	 Tel:

	
	 Fax:

	
	 Email:

	
	DELIVERY INSTRUCTIONS
	 (if different from above)

	
	 c/o:

	
	 Street:

	
	 City/State/Zip:

	
	 Attention:

	
	 Tel:

  

 2 

	
	 AGREED AND ACCEPTED:

	
	 THE SANDS REGENT

	
	 By:

	 Title:

  

 3 

 ANNEX I 
  
 TERMS AND CONDITIONS FOR PURCHASE
OF SHARES 
  
 1. Agreement to
Sell and Purchase the Shares; Subscription Date. 
  
 1.1
Purchase and Sale of Shares. At the Closing (as defined in Section 2), the Company will sell to the Investor, and the Investor will purchase from the Company, upon the terms and conditions hereinafter set forth, the number of Shares set forth in
paragraph 3 of the Stock Purchase Agreement to which these Terms and Conditions for Purchase of Shares are attached as Annex I and at the purchase price set forth in such paragraph. 
  
 1.2 Purchase and Sale of the Warrant. In consideration of the purchase of the Shares by the Investor, upon the
Closing, the Company will issue the Warrant to the Investor, giving the Investor the right to purchase, beginning 6 months after the Closing (as defined in Section 2), up to
                     (            ) shares of Common Stock upon exercise
thereof. 
  
 1.3 Other Investors. As part of the Offering,
the Company proposes to enter into this same form of Stock Purchase Agreement with certain other investors (the “Other Investors”), and the Company expects to complete sales of Securities to them. (The Investor and the Other
Investors are hereinafter sometimes collectively referred to as the “Investors,” and this Agreement and the Stock Purchase Agreements executed by the Other Investors are hereinafter sometimes collectively referred to as the
“Agreements.”) The Company will accept executed Agreements from Investors for the purchase of Securities commencing upon the date on which the Company provides the Investors with the proposed Per Share Purchase Price and concluding
upon the date (the “Subscription Date”) on which the Company has notified Roth Capital Partners, LLC (in its capacity as Placement Agent for the Securities, the “Placement Agent”) in writing that it is no longer
accepting Agreements for the purchase of Securities in the Offering. 
  
 1.4 Placement Agent Fee. Investor acknowledges that the Company intends to pay the Placement Agent a fee in respect of the sale of Securities to the Investor. 
  
 2. Delivery of the Shares at Closing. The completion of the purchase and sale of the Shares (the
“Closing”) and the issuance of the Warrant shall occur at a place and time, no later than December 1, 2004 (the “Closing Date”), to be specified by the Company and the Placement Agent, and of which the Investors
will be notified in advance by the Placement Agent. At the Closing, the Company shall deliver to the Investor (i) one or more stock certificates representing the number of Shares set forth on the signature page hereto, each such certificate to be
registered in the name of the Investor or, if so indicated on the Stock Certificate Questionnaire attached hereto as Exhibit A, in the name of a nominee designated by the Investor provided that, if requested by the Investor, stock certificates
representing such Shares shall be delivered in escrow to such Investor’s agent prior to the Closing, to be held until the completion of the Closing and (ii) the Warrant in an amount determined in accordance with Section 1.2 hereof. In exchange
for the delivery of the stock certificates representing such Shares and the Warrant, on or prior to this Closing Date, the Investor shall deliver the purchase price for such Securities to the Company by wire transfer of immediately available funds
pursuant to the written wire instructions of the Company. 
  
 The
Company’s obligation to issue and sell the Securities, as applicable, to the Investor shall be subject to the following conditions, any one or more of which may be waived by the Company: 
  
 (a) receipt by the Company of the purchase price for the Securities being purchased
hereunder as set forth on the Signature Page hereto; (b) completion of purchases and sales under the Agreements with the Other Investors; and (c) the accuracy of the representations and warranties made by the Investors and the fulfillment of those
undertakings of the Investors to be fulfilled prior to the Closing. 
  

 1 

 The Investor’s obligation to purchase the Securities shall be subject to the following conditions,
any one or more of which may be waived by the Investor: (a) the Company’s agreement to issue and sell, as applicable, and the Investors’ agreement to purchase, on the Closing Date, not less than the amount of Securities set forth in
paragraph 3 of the Stock Purchase Agreement; (b) the delivery to the Investor by counsel to the Company of legal opinions in the form attached hereto as Exhibits D-1, D-2 and D-3; (c) the delivery to the Investor by the Transfer Agent of an executed
certificate in the form attached hereto as Exhibit E; (d) the representations and warranties of the Company contained in Section 3 being true and correct on and as of such Closing with the same effect as though such representations and warranties
had been made on and as of the date of such Closing; (e) the absence of any order, writ, injunction, judgment or decree that questions the validity of the Agreements or the right of the Company to enter into such Agreements or to consummate the
transactions contemplated hereby and thereby; and (f) the delivery to the Investor by the Secretary or Assistant Secretary of the Company of a certificate stating that the condition specified in part (d) of this paragraph, with respect to the
Company, has been fulfilled. 
  
 3. Representations,
Warranties and Covenants of the Company. Except as otherwise described in the Company’s Annual Report on Form 10-K for the year ended June 30, 2004 (and any amendments thereto filed prior to the date hereof), the Company’s Proxy
Statement for its 2004 Annual Meeting of Stockholders or any of the Company’s Current Reports on Form 8-K filed since July 1, 2004 (collectively, the “SEC Reports”), the Company hereby represents and warrants to, and covenants
with, the Investor as of the date hereof and the Closing Date, as follows: 
  
 3.1 Organization. Each of the Company and its Subsidiaries (as defined in Rule 405 under the Securities Act of 1933, as amended (the “Securities Act”)) is duly incorporated and validly existing
in good standing under the laws of the jurisdiction of its organization. Each of the Company and its Subsidiaries has full power and authority to own, operate and occupy its properties and to conduct its business as presently conducted and is
registered or qualified to do business and in good standing in each jurisdiction in which it owns or leases property or transacts business and where the failure to be so qualified would have a material adverse effect upon the Company and its
Subsidiaries taken as a whole, or the business, financial condition, properties, operations or assets of the Company and its Subsidiaries, taken as a whole, or the Company’s ability to perform its obligations under the Agreements
(“Material Adverse Effect”), and to the Company’s knowledge, no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing, or seeking to revoke, limit or curtail, such power and authority or
qualification. 
  
 3.2 Due Authorization. The Company has
all requisite power and authority to execute, deliver and perform its obligations under the Agreements and the Agreements have been duly authorized and validly executed and delivered by the Company and constitute legal, valid and binding agreements
of the Company enforceable against the Company in accordance with their terms, except as rights to indemnity and contribution may be limited by state or federal securities laws or the public policy underlying such laws, except as enforceability may
be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ and contracting parties’ rights generally and except as enforceability may be subject to general principles of equity
(regardless of whether such enforceability is considered in a proceeding in equity or at law). 
  

 2 

 3.3 Non-Contravention. The execution and delivery of the Agreement and the Warrant Agreement, the
issuance and sale of the Securities to be sold by the Company under the Agreement, the fulfillment of the terms of the Agreement and the Warrant Agreement and the consummation of the transactions contemplated thereby will not (A) result in conflict
with or constitute a violation of, or default (with the passage of time or otherwise) under, (i) any bond, debenture, note or other evidence of indebtedness, or any lease, contract, indenture, mortgage, deed of trust, loan agreement, joint venture
or other agreement or instrument to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries or their respective properties are bound, where such conflict, violation or default is reasonably expected
to result in a Material Adverse Effect, or for which consent has been obtained, (ii) the certificate of incorporation, by-laws or other organizational documents of the Company or any of its Subsidiaries, or (iii) any law, administrative regulation,
ordinance or order of any court or governmental agency, arbitration panel or authority binding upon the Company or any of its Subsidiaries or their respective properties, where such conflict, violation or default is likely to result in a Material
Adverse Effect or (B) result in the creation or imposition of any lien, encumbrance, claim, security interest or restriction whatsoever upon any of the material properties or assets of the Company or any of its Subsidiaries or an acceleration of
indebtedness pursuant to any obligation, agreement or condition contained in any material bond, debenture, note or any other evidence of indebtedness or any material indenture, mortgage, deed of trust or any other agreement or instrument to which
the Company or any of its Subsidiaries is a party or by which any of them is bound or to which any of the property or assets of the Company or any of its Subsidiaries is subject. No consent, approval, authorization or other order of, or
registration, qualification or filing with, any regulatory body, administrative agency, or other governmental body in the United States is required for the execution and delivery of the Agreements by the Company and the valid issuance of sale of the
Securities by the Company pursuant to the Agreements, other than such as have been made or obtained, and except for any filings required to be made under federal or state securities laws. 
  
 3.4 Capitalization. The capitalization of the Company as of June 30, 2004 is as described in the Company’s
Annual Report on Form 10-K for the year ended June 30, 2004. The Company has not issued any capital stock since June 30, 2004 other than pursuant to the exercise of employee stock options under the stock option plans disclosed in the SEC Reports.
The Securities to be sold pursuant to the Agreements have been duly authorized, and when issued and paid for in accordance with the terms of the Agreements, will be duly and validly issued, fully paid and nonassessable. The outstanding shares of
capital stock of the Company have been duly and validly issued and are fully paid and nonassessable, have been issued in compliance with the registration requirements of federal and state securities laws, and were not issued in violation of any
preemptive rights or similar rights to subscribe for or purchase securities. Except for (i) options issued under the Company’s stock option plans, (ii) the Warrant dated March 25, 2004 issued by the Company to David R. Belding, (iii) the
Secured Note dated March 25, 2004 issued by the Company to David R. Belding (the “Note”), (iv) a Non-Qualified Stock Option Agreement dated May 11, 1998 by and between the Company and Louis J. Phillips and (v) 61,349 shares of
Common Stock issued upon the partial conversion of the Note in accordance with its terms, there are no outstanding rights (including, without limitation, preemptive rights), warrants or options to acquire, or instruments convertible into or
exchangeable for, any unissued shares of capital stock or other equity interest in the Company or any of its Subsidiaries, or any contract, commitment, agreement, understanding or arrangement of any kind, in either case to which the Company or any
of its Subsidiaries is a party and providing for the issuance or sale of any capital stock of the Company or any of its Subsidiaries, any such convertible or exchangeable securities or any such rights, warrants or options. Without limiting the
foregoing, no preemptive right, co-sale right, registration right, right of first refusal or other similar right exists with respect to the issuance and sale of the Securities, except as provided in the Agreements. There are no stockholders
agreements, voting agreements or other similar agreements with respect to the Common Stock to which the Company is a party. Other than the pledge of securities 
  

 3 

 of the Company’s Subsidiaries pursuant to the Credit Agreement with Wells Fargo, National Association, dated as of
April 2, 2004, the Company owns the entire equity interest in its Subsidiaries, free and clear of any pledge, lien, security interest, encumbrance, claim or equitable interest. 
  
 3.5 Reservation of Shares. The Company will at all times have authorized, and reserved for the purpose of issuance, a
sufficient number of shares of Common Stock to provide for the full exercise of the Warrants and the issuance of the Warrant Shares in connection with the Agreements. Prior to the expiration thereof, the Company will not reduce the number of shares
of Common Stock reserved for issuance upon exercise of the Warrants without the consent of the Investor. If at any time the number of shares of Common Stock authorized and reserved for issuance is below the number of Warrant Shares issuable upon
exercise of the Warrants, the Company will promptly take all corporate action necessary to authorize and reserve a sufficient number of shares, including, without limitation, calling a special meeting of shareholders to authorize additional shares
to meet the Company’s obligations under this Section 3.5, in the case of an insufficient number of authorized shares, and using its reasonable best efforts to obtain shareholder approval of an increase in such authorized number of shares.

  
 3.6 Legal Proceedings. There is no material legal or
governmental proceeding pending, or to the knowledge of the Company, threatened, to which the Company or any of its Subsidiaries is a party or of which the business or property of the Company or any of its Subsidiaries is subject. Neither the
Company nor any Subsidiary is a party to the provisions of any injunction, judgment, decree or order of any court, regulatory body, administrative agency or other government body which is material to the business or operation of the Company and its
Subsidiaries, taken as a whole. 
  
 3.7 No Violations.
Neither the Company nor any of its Subsidiaries is in violation of its certificate of incorporation, bylaws or other organizational documents, or in violation of any law, administrative regulation, ordinance or order of any court or governmental
agency, arbitration panel or authority applicable to the Company or any of its Subsidiaries, which violation, individually or in the aggregate, is reasonably likely to have a Material Adverse Effect, nor is the Company or any of its Subsidiaries in
default (and there exists no condition which, with the passage of time or otherwise, would constitute a default) in the performance of any bond, debenture, note or any other evidence of indebtedness or any indenture, mortgage, deed of trust or any
other material agreement or instrument to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound or by which the property of the Company or any of its Subsidiaries is bound, which default
is reasonably likely to have a Material Adverse Effect. 
  
 3.8
Governmental Permits, Etc. Each of the Company and its Subsidiaries has all necessary franchises, licenses, certificates and other authorizations from any foreign, federal, state or local government or governmental agency, department or body
that are currently necessary for the operation of the business of the Company and its Subsidiaries as currently conducted, except where the failure to currently possess such franchises, licenses, certificates and other authorizations is not
reasonably expected to have a Material Adverse Effect. 
  
 3.9
Intellectual Property. 
  
 (a) Except for matters
which are not reasonably likely to have a Material Adverse Effect, (i) each of the Company and its Subsidiaries has ownership of, or a license or other legal right to use, all patents, copyrights, trade secrets, trademarks, customer lists, designs,
manufacturing or other processes, computer software, systems, data compilation, research results or other proprietary rights used in the business of the Company or its Subsidiaries (collectively, “Intellectual Property”) and (ii)
all of the Intellectual Property owned by the Company or its Subsidiaries consisting of patents, registered 
  

 4 

 trademarks and registered copyrights have been duly registered in, filed in or issued by the United States Patent and
Trademark Office, the United States Register of Copyrights or the corresponding offices of other jurisdictions and have been maintained and renewed in accordance with all applicable provisions of law and administrative regulations in the United
States and/or such other jurisdictions. 
  
 (b) Except for
matters which are not reasonably likely to have a Material Adverse Effect, all material licenses or other material agreements under which (i) the Company or any of its Subsidiaries employs rights in Intellectual Property, or (ii) the Company or any
of its Subsidiaries has granted rights to others in Intellectual Property owned or licensed by the Company or any of its Subsidiaries, are in full force and effect and there is no default by the Company or any of its Subsidiaries thereto.

  
 (c) Except for matters which are not reasonably likely
to have a Material Adverse Effect, to the knowledge of the Company, (i) the present business, activities and products of the Company and its Subsidiaries do not infringe any intellectual property of any other person; (ii) neither the Company nor any
of its Subsidiaries is making unauthorized use of any confidential information or trade secrets of any person; and (iii) the activities of any of the employees on behalf of the Company or any of its Subsidiaries do not violate any agreements or
arrangements related to confidential information or trade secrets of persons other than the Company or its Subsidiaries or restricting any such employee’s engagement in business activities of any nature. 
  
 (d) No proceedings are pending, or to the knowledge of the Company,
threatened, which challenge the rights of the Company or any of its Subsidiaries in respect of the Company’s or any of its Subsidiaries’ right to the use of the Intellectual Property, except for matters which are not reasonably likely to
have a Material Adverse Effect. 
  
 3.10 Financial Statements.
The consolidated financial statements of the Company and the related notes contained in the SEC Reports present fairly, in accordance with generally accepted accounting principles, the consolidated financial position of the Company and its
Subsidiaries as of the dates indicated, and the results of their operations, cash flows and the changes in stockholders’ equity for the periods therein specified, subject, in the case of unaudited financial statements for interim periods, to
normal year-end audit adjustments. Such consolidated financial statements (including the related notes) have been prepared in accordance with generally accepted accounting principles applied on a consistent basis throughout the periods therein
specified, except that unaudited financial statements may not contain all footnotes required by generally accepted accounting principles. 
  
 3.11 No Material Adverse Change. Since June 30, 2004, there has not been (i) a change that has had or is reasonably likely to have a Material
Adverse Effect, (ii) any obligation, direct or contingent, that is material to the Company or any of its Subsidiaries considered as one enterprise, incurred by the Company or any of its Subsidiaries, except obligations incurred in the ordinary
course of business, (iii) any dividend or distribution of any kind declared, paid or made on the capital stock of the Company or any of its Subsidiaries, or (iv) any loss or damage (whether or not insured) to the physical property of the Company or
any of its Subsidiaries which has been sustained which has had a Material Adverse Effect. 
  
 3.12 Nasdaq Compliance. The Company’s Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is listed on the
Nasdaq SmallCap Market (the “Nasdaq SmallCap Market”), and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange
Act or delisting the Common Stock from the Nasdaq SmallCap Market. The issuance of the Securities does not require shareholder approval, including, without limitation, pursuant to the Nasdaq Marketplace Rules. 
  

 5 

 3.13 Reporting Status. The Company has timely made all filings required under the Exchange Act
during the 12 months preceding the date of this Agreement, and all of those documents complied in all material respects with the SEC’s requirements as of their respective filing dates, and the information contained therein as of the respective
dates thereof did not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein in light of the circumstances under which they were made not misleading.
The Company is currently eligible to register the resale of Common Stock in a secondary offering on a registration statement on Form S-3 under the Securities Act. 
  
 3.14 No Manipulation of Stock. The Company has not taken and will not, in violation of applicable law, take any
action outside the ordinary course of business designed to or that might reasonably be expected to cause or result in unlawful manipulation of the price of the Common Stock to facilitate the sale or resale of the Shares or the Warrant Shares.

  
 3.15 Accountants. Deloitte & Touche LLP, who
expressed their opinion with respect to the consolidated financial statements to be incorporated by reference from the Company’s Annual Report on Form 10-K for the year ended June 30, 2004 into the Registration Statement (as defined below) and
the prospectus which forms a part thereof (the “Prospectus”), have advised the Company that they are, and to the best knowledge of the Company they are, independent accountants as required by the Securities Act and the rules and
regulations promulgated thereunder (the “Rules and Regulations”). 
  
 3.16 Contracts. Except for matters which are not reasonably likely to have a Material Adverse Effect, the contracts listed as exhibits to the SEC Reports that are material to the Company, other than those
contracts that are substantially or fully performed or expired by their terms, are in full force and effect on the date hereof, and none of the Company, its Subsidiaries nor, to the Company’s knowledge, any other party to such contracts is in
breach of or default under any of such contracts. 
  
 3.17
Taxes. Except for matters which are not reasonably expected to have a Material Adverse Effect, the Company has filed all necessary federal, state and foreign income and franchise tax returns and has paid or accrued all taxes shown as due
thereon, and the Company has no knowledge of a tax deficiency which has been asserted or threatened against the Company. 
  
 3.18 Transfer Taxes. On the Closing Date, all stock transfer or other taxes (other than income taxes) which are required to be paid in connection
with the sale and transfer of the Shares hereunder will be, or will have been, fully paid or provided for by the Company and the Company will have complied with all laws imposing such taxes. 
  
 3.19 Investment Company. The Company is not an “investment
company” or an “affiliated person” of, or “promoter” or “principal underwriter” for an investment company, within the meaning of the Investment Company Act of 1940, as amended. 
  
 3.20 Insurance. The Company and its Subsidiaries maintain insurance of
the types and in the amounts that the Company reasonably believes is adequate for the their businesses, including, but not limited to, insurance covering real and personal property owned or leased by the Company and its Subsidiaries against theft,
damage, destruction, acts of vandalism and all other risks customarily insured against by similarly situated companies, all of which insurance is in full force and effect. 
  

 6 

 3.21 Offering Materials. The Company has not in the past nor will it hereafter take any action to
sell, offer for sale or solicit offers to buy any securities of the Company which would be integrated with the offer or sale of the Shares as contemplated by this Agreement such that the offer and Sale of the shares would be brought within the
provisions of Section 5 of the Securities Act. 
  
 3.22 General
Solicitation. The Company has not engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with any offer or sale of the Securities in the United States. 
  
 3.23 Registration. Subject to the accuracy of the representations of
the Investor set forth in Section 4 herein, the sale of the Securities by the Company pursuant to this Agreement does not require registration under the Securities Act or under any stock securities laws or blue sky laws. 
  
 3.24 Listing. The Company will use its best efforts to maintain the
listing and trading of its Common Stock (including the Common Shares and the Warrant Shares) on the Nasdaq SmallCap Market and will comply with all the requirements of the NASD and the Nasdaq SmallCap Market. 
  
 3.25 Related Party Transactions. Except for the sale of Securities
under the Agreements, no transaction has occurred between or among the Company, any of the Subsidiaries and their affiliates, officers or directors or any affiliate or affiliates of any such officer or director that with the passage of time will be
required to be disclosed pursuant to Section 13, 14 or 15(d) of the Exchange Act. 
  
 3.26 Non-public Information. The Company confirms that, neither the Company nor any other person acting on its behalf has provided the Investor or its agents or counsel with any information that constitutes
material, non-public information, except as will be disclosed in accordance with Section 13 below. The Company understands and confirms that the Investor will rely on the foregoing representations and covenants in effecting transactions contemplated
by this Agreement. None of the disclosures provided to the Investor regarding the Company and its business set forth in the SEC Reports, this Agreement, or any other documents provided in connection with the transactions contemplated hereby, contain
any untrue statement of a material fact or omit to stat any material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. 
  
 3.27 Books and Records. The books, records and accounts of the Company
and the Subsidiaries accurately and fairly reflect, in reasonable detail, the transactions in, and dispositions of, the assets of, and the operations of, the Company and the Subsidiaries. The Company maintains a system of internal accounting
controls sufficient to provide reasonable assurances that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. 
  
 4. Representations, Warranties and Covenants of the Investor. 
  
 4.1 Investor Knowledge and Status. The Investor represents and warrants to, and covenants with, the Company that: (i)
the Investor is an “accredited investor” as defined in Regulation D under the Securities Act and has requested, received, reviewed and considered all information it deemed relevant in making an informed decision to purchase the Securities;
(ii) the Investor understands that the 
  

 7 

 Securities are “restricted securities” and have not been registered under the Securities Act and is acquiring
the Securities set forth on the Signature Page hereto in the ordinary course of its business and for its own account for investment only, has no present intention of distributing any of such Securities and has no arrangement or understanding with
any other persons regarding the distribution of such Securities (this representation and warranty not limiting the Investor’s right to sell Securities pursuant to the Registration Statement or otherwise, or other than with respect to any claim
arising out of a breach of this representation and warranty, the Investor’s right to indemnification under Section 6.3); (iii) the Investor will not, directly or indirectly, offer, sell, pledge, transfer or otherwise dispose of (or solicit any
offers to buy, purchase or otherwise acquire or take a pledge of) any of the Securities except in compliance with the Securities Act, applicable state securities laws and the respective rules and regulations promulgated thereunder; (iv) the Investor
has answered all questions on the Signature Page hereto and the Investor Questionnaire attached hereto as Exhibit B for use in preparation of the Registration Statement and the answers thereto are true and correct as of the date hereof and will be
true and correct as of the Closing Date; (v) the Investor will notify the Company immediately of any change in any of such information until such time as the Investor has sold all of its Securities or until the Company is no longer required to keep
the Registration Statement effective; and (vi) the Investor has, in connection with its decision to purchase the Securities set forth on the signature page hereto, relied only upon the representations and warranties of the Company contained herein.
Investor understands that the issuance of the Securities to the Investor has not been registered under the Securities Act, or registered or qualified under any state securities law in reliance on specific exemptions therefrom, which exemptions may
depend upon, among other things, the bona fide nature of the Investor’s investment intent as expressed herein. The Placement Agent is not authorized to make any representation or use any information in connection with the placement, purchase
and sale of the Securities, and no person is authorized to provide any representation which is inconsistent or in addition to those in the SEC Reports. The Investor acknowledges that it has not received or relied on any such representations.

  
 4.2 International Actions. The Investor acknowledges,
represents and agrees that no action has been or will be taken in any jurisdiction outside the United States by the Company or the Placement Agent that would permit an offering of the Securities, or possession or distribution of offering materials
in connection with the issue of the Securities, in any jurisdiction outside the United States. If the Investor is located outside the United States, it has or will take all actions necessary for the sale of the Securities to comply with all
applicable laws and regulations in each foreign jurisdiction in which it purchases, offers, sells or delivers Securities or has in its possession or distributes any offering material, in all cases at its own expense. 
  
 4.3 Registration Required. The Investor hereby covenants with the
Company not to make any sale of the Securities without complying with the provisions of this Agreement, including Section 6.2 hereof, and without effectively causing the prospectus delivery requirement under the Securities Act to be satisfied
(unless the Investor is selling such Securities in a transaction not subject to the prospectus delivery requirement), and the Investor acknowledges that the certificates evidencing the Shares and/or Warrant Shares will be imprinted with a legend
that prohibits their transfer except in accordance therewith. The Investor acknowledges that as set forth in, and subject to the provisions of, Section 6.2, there may occasionally be times when the Company, based on the advice of its counsel,
determines that it must suspend the use of the Prospectus forming a part of the Registration Statement until such time as an amendment to the Registration Statement has been filed by the Company and declared effective by the SEC or until the Company
has amended or supplemented such Prospectus. 
  
 4.4 Power and
Authority. The Investor further represents and warrants to, and covenants with, the Company that (i) the Investor has full right, power, authority and capacity to enter into this Agreement and to consummate the transactions contemplated hereby
and has taken all necessary 
  

 8 

 action to authorize the execution, delivery and performance of this Agreement, and (ii) this Agreement constitutes a
valid and binding obligation of the Investor enforceable against the Investor in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting
creditors’ and contracting parties’ rights generally and except as enforceability may be subject to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law) and except as
the indemnification agreements of the Investors herein may be legally unenforceable. 
  
 4.5 No Dispositions. Except with the prior written consent of the Company, the Investor will not, prior to the effectiveness of the Registration Statement, or, if earlier, 60 days from the Closing Date, sell,
offer to sell, solicit offers to buy, dispose of, loan, pledge or grant any right with respect to (collectively, a “Disposition”), the Common Stock of the Company, nor will Investor engage in any hedging or other transaction which
is designed to or could reasonably be expected to lead to or result in a Disposition of Common Stock of the Company by the Investor or any other person or entity. Such prohibited hedging or other transactions would include, without limitation,
effecting any short sale or having in effect any short position (whether or not such sale or position is against the box and regardless of when such position was entered into) or any purchase, sale or grant of any right (including, without
limitation, any put or call option) with respect to the Common Stock of the Company or with respect to any security (other than a broad-based market basket or index) that includes, relates to or derives any significant part of its value from the
Common Stock of the Company. 
  
 4.6 No Tax or Legal
Advice. The Investor understands that nothing in this Agreement, or any other materials presented to the Investor in connection with the purchase and sale of the Shares constitutes legal, tax or investment advice. The Investor has consulted such
legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of Shares. 
  
 4.7 Certain Trading Activities. Such Investor has not directly or indirectly, nor has any person acting on behalf of or pursuant to any
understanding with such Investor, engaged in any transactions in the securities of the Company (including, without limitations, any short sales involving the Company’s securities) since the earlier of (1) the 20th trading day preceding the date of this Agreement and (2) the time that such Investor was first contacted by the Company, the
Placement Agent or any other person regarding an investment in the Company. Such Investor covenants that neither it nor any person acting on its behalf or pursuant to any understanding with it will engage in any transactions in the securities of the
Company (including short sales) prior to the time that the transactions contemplated by this Agreement are publicly disclosed by the Company. Such Investor has maintained, and covenants that until such time as the transactions contemplated by this
Agreement are publicly disclosed by the Company, such Investor will maintain the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). 
  
 4.8 Compliance with Gaming Laws. Such investor agrees to comply with
all applicable Nevada state gaming laws, including but not limited to, the requirement that in the event such investor acquires more than 5% of the Company’s capital stock the Investor must report such acquisition to the Nevada Gaming
Commission. 
  
 5. Survival of Representations, Warranties and
Agreements. Notwithstanding any investigation made by any party to this Agreement or by the Placement Agent, all covenants, agreements, representations and warranties made by the Company and the Investor herein shall survive the execution of
this Agreement, the delivery to the Investor of the Shares being purchased and the payment therefor. 
  

 9 

 6. Registration of the Shares; Compliance with the Securities Act. 
  
 6.1 Registration Procedures and Expenses. The Company shall:

  
 (a) subject to receipt of necessary information from
the Investors, prepare and file with the SEC, as soon as practicable, but in no event later than thirty (30) days after the Closing Date, a registration statement on Form S-3 (the “Registration Statement”) to enable the resale of
the Shares and the Warrant Shares by the Investors from time to time through the automated quotation system of the Nasdaq SmallCap Market or in privately-negotiated transactions; 
  
 (b) use its best efforts, subject to receipt of necessary information from the Investors, to cause the Registration
Statement to become effective as soon as practicable, but in no event later than ninety (90) days after the Closing. If the Registration Statement has not been declared effective by the SEC on or before the date that is 90 days after the Closing
Date, the Company shall, on the 121st day after the Closing Date and each 30th day thereafter, pay to the Investor an amount in cash equal to 1% of the aggregate purchase price of the common stock purchased by such Investor. Any
such amounts due pursuant to this Section 6.1(b) shall be pro rated for periods of less than 30 days; 
  
 (c) use its best efforts to prepare and file with the SEC such amendments and supplements to the Registration Statement and the Prospectus used in
connection therewith as may be necessary to keep the Registration Statement current and effective for a period not exceeding, with respect to each Investor’s Shares purchased hereunder, the earlier of (i) the second anniversary of the Closing
Date, (ii) the date on which the Investor may sell all Shares then held by the Investor without restriction by the volume limitations of Rule 144(e) of the Securities Act or (iii) such time as all Shares purchased by such Investor in this Offering
have been sold pursuant to a registration statement; 
  
 (d)
furnish to the Investor with respect to the Shares and Warrant Shares registered under the Registration Statement (i) one copy of the Prospectus within two days after the Registration Statement is declared effective by the SEC and (ii) such
number of copies of the Registration Statement, Prospectuses (including supplemental prospectuses) and preliminary versions of the Prospectus filed with the Securities Exchange Commission (“Preliminary Prospectuses”) in conformity
with the requirements of the Securities Act and such other documents as the Investor may reasonably request, in order to facilitate the public sale or other disposition of all or any of the Shares and Warrant Shares by the Investor, provided,
however, that unless waived by the Company in writing, the obligation of the Company to deliver copies of Prospectuses or Preliminary Prospectuses to the Investor shall be subject to the receipt by the Company of reasonable assurances from the
Investor that the Investor will comply with the applicable provisions of the Securities Act and of such other securities or blue sky laws as may be applicable in connection with any use of such Prospectuses or Preliminary Prospectuses; 

 
 (e) file documents required of the Company for normal blue sky
clearance in all states requiring blue sky clearance; provided, however, that the Company shall not be required to qualify to do business in any jurisdiction in which it is not now so qualified or has not so consented; 
  
 (f) bear all expenses (other than underwriting discounts and
commissions, if any) in connection with the procedures in paragraph (a) through (e) of this Section 6.1 and the registration of the Shares and Warrant Shares pursuant to the Registration Statement; and 
  
 (g) advise the Investors, promptly after it shall receive notice or
obtain knowledge of the issuance of any stop order by the SEC delaying or suspending the effectiveness of the Registration Statement or of the initiation of any proceeding for that purpose; and it will promptly use its commercially reasonable
efforts to prevent the issuance of any stop order or to obtain its withdrawal at the earliest possible moment if such stop order should be issued. 
  

 10 

 With a view to making available to the Investor the benefits of Rule 144 (or its successor rule) and any other rule or
regulation of the SEC that may at any time permit the Investor to sell Securities to the public without registration, the Company covenants and agrees to: (i) make and keep public information available, as those terms are understood and defined in
Rule 144, until the earlier of (A) such date as all of the Investor’s Securities may be resold pursuant to Rule 144(k) or any other rule of similar effect or (B) such date as all of the Investor’s Securities shall have been resold; (ii)
file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and under the Exchange Act; and (iii) furnish to the Investor upon request, as long as the Investor owns any Shares or Warrant
Shares, (A) a written statement by the Company that it has complied with the reporting requirements of the Securities Act and the Exchange Act, (B) a copy of the Company’s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q,
and (C) such other information as may be reasonably requested in order to avail the Investor of any rule or regulation of the SEC that permits the selling of any such Shares or Warrant Shares without registration. 
  
 It shall be a condition precedent to the obligations of the Company to take
any action pursuant to this Section 6.1 that the Investor shall furnish to the Company such information regarding itself, the Securities to be sold by Investor, and the intended method of disposition of such securities as shall be required to effect
the registration of the Securities. 
  
 The Company understands
that the Investor disclaims being an underwriter, but the Investor being deemed an underwriter by the SEC shall not relieve the Company of any obligations it has hereunder. 
  
 6.2 Transfer of Shares After Registration; Suspension. 
  
 (a) The Investor agrees that it will not effect any Disposition of the Securities or its right to purchase the
Securities that would constitute a sale within the meaning of the Securities Act other than transactions exempt from the registration requirements of the Securities Act, except as contemplated in the Registration Statement referred to in Section 6.1
and as described below, and that it will promptly notify the Company of any changes in the information set forth in the Registration Statement regarding the Investor or its plan of distribution. 
  
 (b) Except in the event that paragraph (c) below applies, the Company
shall: (i) if deemed necessary by the Company, prepare and file from time to time with the SEC a post-effective amendment to the Registration Statement or a supplement to the related Prospectus or a supplement or amendment to any document
incorporated therein by reference or file any other required document so that such Registration Statement will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein not misleading, and so that, as thereafter delivered to purchasers of the Securities being sold thereunder, such Prospectus will not contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; (ii) provide the Investor copies of any documents filed pursuant to Section 6.2(b)(i); and (iii) upon request,
inform each Investor who so requests that the Company has complied with its obligations in Section 6.2(b)(i) (or that, if the Company has filed a post-effective amendment to the Registration Statement which has not yet been declared effective, the
Company will notify the Investor to that effect, will use its reasonable efforts to secure the effectiveness of such post-effective amendment as promptly as possible and will promptly notify the Investor pursuant to Section 6.2(b)(i) hereof when the
amendment has become effective). 
  

 11 

 (c) Subject to paragraph (d) below, in the event: (i) of any request by the SEC or any other
federal or state governmental authority during the period of effectiveness of the Registration Statement for amendments or supplements to a Registration Statement or related Prospectus or for additional information; (ii) of the issuance by the SEC
or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration Statement or the initiation of any proceedings for that purpose; (iii) of the receipt by the Company of any notification with
respect to the suspension of the qualification or exemption from qualification of any of the Securities for sale in any jurisdiction or the initiation of any proceeding for such purpose; or (iv) of any event or circumstance which necessitates the
making of any changes in the Registration Statement or Prospectus, or any document incorporated or deemed to be incorporated therein by reference, so that, in the case of the Registration Statement, it will not contain any untrue statement of a
material fact or any omission to state a material fact required to be stated therein or necessary to make the statements therein not misleading, and that in the case of the Prospectus, it will not contain any untrue statement of a material fact or
any omission to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; then the Company shall promptly deliver a certificate in
writing to the Investor (the “Suspension Notice”) to the effect of the foregoing and, upon receipt of such Suspension Notice, the Investor will refrain from selling any Shares pursuant to the Registration Statement (a
“Suspension”) until the Investor’s receipt of copies of a supplemented or amended Prospectus prepared and filed by the Company, or until it is advised in writing by the Company that the current Prospectus may be used, and has
received copies of any additional or supplemental filings that are incorporated or deemed incorporated by reference in any such Prospectus. In the event of any Suspension, the Company will use its reasonable efforts to cause the use of the
Prospectus so suspended to be resumed as soon as reasonably practicable within 30 days after delivery of a Suspension Notice to the Investors. In addition to and without limiting any other remedies (including, without limitation, at law or at
equity) available to the Investor, the Investor shall be entitled to specific performance in the event that the Company fails to comply with the provisions of this Section 6.2(c). 
  
 (d) Notwithstanding the foregoing paragraphs of this Section 6.2, the Company shall use its best efforts to ensure
that the Investor shall not be prohibited from selling Securities under the Registration Statement as a result of Suspensions on more than one occasion of not more than 30 days in any twelve month period. If a Suspension is in effect for more than
60 days (consecutive or non-consecutive) in any twelve-month period, the Company shall, on the 61st day of the
Suspension and each 30th day thereafter, pay to the Investor an amount in cash equal to 1% of the aggregate purchase
price of the common stock purchased by such Investor. Any such amounts due pursuant to this Section 6.1(b) shall be pro rated for periods of less than 30 days. 
  

(e) Provided that a Suspension is not then in effect the Investor may sell Securities under the Registration Statement, provided that it
arranges for delivery of a current Prospectus to the transferee of such Securities. Upon receipt of a request therefor, the Company will provide an adequate number of current Prospectuses to the Investor and to any other parties requiring such
Prospectuses. 
  
 (f) In the event of a sale of Securities
by the Investor, unless such requirement is waived by the Company in writing, the Investor must also deliver to the Company’s transfer agent a Certificate of Subsequent Sale in the form attached hereto as Exhibit C, so that the Securities may
be properly transferred. 
  

 12 

 In the event of any sale of the Shares and/or the Warrant Shares in accordance with this Agreement, the
restrictive legend shall be removed and the Company shall issue a certificate without such legend to the purchaser of any such Shares and/or the Warrant Shares, if (a) the sale of such Shares and/or the Warrant Shares is registered under the
Registration Statement (including registration pursuant to Rule 415 under the Securities Act); (b) the holder has provided the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable
transactions, to the effect that a public sale or transfer of such Shares and/or Warrant Shares may be made without registration under the Securities Act; or (c) such Shares and/or Warrant Shares are sold in compliance with Rule 144 under the
Securities Act. 
  
 6.3 Indemnification. For the purpose of
this Section 6.3: 
  
 (a) the term
“Investor” shall include the Investor and each person, if any, who controls the Investor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act; 
  
 (b) the term “Registration Statement” shall include
any final Prospectus, exhibit, supplement or amendment included in or relating to, and any document incorporated by reference in, the Registration Statement (or deemed to be a part thereof) referred to in Section 6.1; and 
  
 (c) the term “untrue statement” shall include any
untrue statement or alleged untrue statement, or any omission or alleged omission to state in the Registration Statement a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading. 
  
 (d)

  
 (i) The Company agrees to indemnify and hold harmless
each Investor from and against any losses, claims, damages or liabilities to which such Investor may become subject (under the Securities Act or otherwise) insofar as such losses, claims, damages or liabilities (or actions or proceedings in respect
thereof) arise out of, or are based upon (i) any untrue statement of a material fact contained in the Registration Statement, (ii) any inaccuracy in the representations and warranties of the Company contained in the Agreement or the failure of the
Company to perform its obligations hereunder or (iii) any failure by the Company to fulfill any undertaking included in the Registration Statement, and the Company will reimburse such Investor for any reasonable legal or other expenses reasonably
incurred in investigating, defending or preparing to defend any such action, proceeding or claim, provided, however, that the Company shall not be liable in any such case to the extent that such loss, claim, damage or liability arises out of, or is
based upon, an untrue statement made in such Registration Statement in reliance upon and in conformity with written information furnished to the Company by or on behalf of such Investor specifically for use in preparation of the Registration
Statement or the failure of such Investor to comply with its covenants and agreements contained in Sections 4 or 6.2 hereof or any statement or omission in any Prospectus that is corrected in any subsequent Prospectus that was delivered to the
Investor prior to the pertinent sale or sales by the Investor. 
  
 (ii) The Investor agrees to indemnify and hold harmless the Company (and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act, each officer of the Company who signs the Registration
Statement and each director of the Company) from and against any losses, claims, damages or liabilities to which the Company (or any such officer, director or controlling person) may become subject (under the Securities Act or otherwise),

  

 13 

 in so far as such losses, claims, damages or liabilities (or actions or proceedings in respect thereof) arise out of, or
are based upon, (i) any failure to comply with the covenants and agreements contained in Section 4 or 6.2 hereof, or (ii) any untrue statement of a material fact contained in the Registration Statement if such untrue statement was made in reliance
upon and in conformity with written information furnished by or on behalf of the Investor specifically for use in preparation of the Registration Statement, and the Investor will reimburse the Company (or such officer, director or controlling
person), as the case may be, for any legal or other expenses reasonably incurred in investigating, defending or preparing to defend any such action, proceeding or claim. The obligation to indemnify shall be limited to the net amount of the proceeds
received by the Investor from the sale of the Shares pursuant to the Registration Statement. 
  
 (iii) Promptly after receipt by any indemnified person of a notice of a claim or the beginning of any action in respect of which indemnity is to be sought against an indemnifying person pursuant to this Section
6.3, such indemnified person shall notify the indemnifying person in writing of such claim or of the commencement of such action, but the omission to so notify the indemnifying party will not relieve it from any liability which it may have to any
indemnified party under this Section 6.3 (except to the extent that such omission materially and adversely affects the indemnifying party’s ability to defend such action) or from any liability otherwise than under this Section 6.3. Subject to
the provisions hereinafter stated, in case any such action shall be brought against an indemnified person, the indemnifying person shall be entitled to participate therein, and, to the extent that it shall elect by written notice delivered to the
indemnified party promptly after receiving the aforesaid notice from such indemnified party, shall be entitled to assume the defense thereof, with counsel reasonably satisfactory to such indemnified person. After notice from the indemnifying person
to such indemnified person of its election to assume the defense thereof (unless it has failed to assume the defense thereof and appoint counsel reasonably satisfactory to the indemnified party), such indemnifying person shall not be liable to such
indemnified person for any legal expenses subsequently incurred by such indemnified person in connection with the defense thereof, provided, however, that if there exists or shall exist a conflict of interest that would make it inappropriate, in the
reasonable opinion of counsel to the indemnified person, for the same counsel to represent both the indemnified person and such indemnifying person or any affiliate or associate thereof, the indemnified person shall be entitled to retain its own
counsel at the expense of such indemnifying person; provided, however, that no indemnifying person shall be responsible for the fees and expenses of more than one separate counsel (together with appropriate local counsel) for all indemnified
parties. In no event shall any indemnifying person be liable in respect of any amounts paid in settlement of any action unless the indemnifying person shall have approved the terms of such settlement; provided that such consent shall not be
unreasonably withheld. No indemnifying person shall, without the prior written consent of the indemnified person, effect any settlement of any pending or threatened proceeding in respect of which any indemnified person is or could reasonably have
been a party and indemnification could have been sought hereunder by such indemnified person, unless such settlement includes an unconditional release of such indemnified person from all liability on claims that are the subject matter of such
proceeding. 
  
 (iv) If the indemnification provided for
in this Section 6.3 is unavailable to or insufficient to hold harmless an indemnified party under subsection (a) or (b) above in respect of any losses, claims, damages or liabilities (or actions or proceedings in respect thereof) referred to
therein, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect
the relative fault of the Company on the one hand and the Investor on the other in connection with the statements or omissions or other matters which resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as
any other relevant equitable considerations. The relative fault shall be determined by reference to, among other things, in 
  

 14 

 the case of an untrue statement, whether the untrue statement relates to information supplied by the Company on the one
hand or the Investor on the other and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such untrue statement. The Company and the Investor agree that it would not be just and equitable if
contribution pursuant to this subsection (d) were determined by pro rata allocation (even if the Investors were treated as one entity for such purpose) or by any other method of allocation which does not take into account the equitable
considerations referred to above in this subsection (d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect thereof) referred to above in this subsection (d) shall be
deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this subsection (d), the Investor shall not be
required to contribute any amount in excess of the amount by which the gross amount received by the Investor from the sale of the Shares to which such loss relates exceeds the amount of any damages which the Investor has otherwise been required to
pay by reason of such untrue statement. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Investors’ obligations in this subsection to contribute are several in proportion to their sales of Securities to which such loss relates and not joint. 
  
 (v) The parties to this Agreement hereby acknowledge that they are sophisticated business persons who were
represented by counsel during the negotiations regarding the provisions hereof including, without limitation, the provisions of this Section 6.3, and are fully informed regarding said provisions. They further acknowledge that the provisions of this
Section 6.3 fairly allocate the risks in light of the ability of the parties to investigate the Company and its business in order to assure that adequate disclosure is made in the Registration Statement as required by the Securities Act and the
Exchange Act. 
  
 6.4 Termination of Conditions and
Obligations. The conditions precedent imposed by Section 4 or this Section 6 upon the transferability of the Securities shall cease and terminate as to any particular Securities when such Securities shall have been effectively registered under
the Securities Act and sold or otherwise disposed of in accordance with the intended method of disposition set forth in the Registration Statement covering such Securities or at such time as an opinion of counsel satisfactory to the Company shall
have been rendered to the effect that such conditions are not necessary in order to comply with the Securities Act. 
  
 6.5 Information Available. So long as the Registration Statement is effective covering the resale of Securities owned by the Investor, the Company
will furnish (or to the extent such information is available electronically through the Company’s filings with the SEC, the Company will make available) to the Investor: 
  
 (a) as soon as practicable after it is available, one copy of (i) its Annual Report to Stockholders (which Annual
Report shall contain financial statements audited in accordance with generally accepted accounting principles by a national firm of certified public accountants) and (ii) if not included in substance in the Annual Report to Stockholders, its Annual
Report on Form 10-K (the foregoing, in each case, excluding exhibits); 
  
 (b) upon the reasonable request of the Investor, all exhibits excluded by the parenthetical to subparagraph (a)(ii) of this Section 6.5 as filed with the SEC and all other information that is made available to stockholders; and

  

 15 

 (c) upon the reasonable request of the Investor, an adequate number of copies of the Prospectuses
to supply to any other party requiring such Prospectuses; and the Company, upon the reasonable request of the Investor, will meet with the Investor or a representative thereof at the Company’s headquarters to discuss all information relevant
for disclosure in the Registration Statement covering the Securities and will otherwise reasonably cooperate with the Investor conducting an investigation for the purpose of reducing or eliminating the Investor’s exposure to liability under the
Securities Act, including the reasonable production of information at the Company’s headquarters; provided, that the Company shall not be required to disclose any confidential information to or meet at its headquarters with the Investor until
and unless the Investor shall have entered into a confidentiality agreement in form and substance reasonably satisfactory to the Company with the Company with respect thereto. 
  
 6.6 Public Statements. The Company will not issue any public statement, press release or any other public disclosure
listing Investor as one of the purchasers of the Securities without Investor’s prior written consent, except as may be required by applicable law or rules of any exchange on which the Company’s securities are listed. 
  
 7. Notices. All notices, requests, consents and other communications
hereunder shall be in writing, shall be mailed (A) if within domestic United States by first-class registered or certified airmail, or nationally recognized overnight express courier, postage prepaid, or by facsimile, or (B) if delivered from
outside the United States, by International Federal Express (or comparable service) or facsimile, and shall be deemed given (i) if delivered by first-class registered or certified mail domestic, three business days after so mailed, (ii) if delivered
by nationally recognized overnight carrier, one (1) business day after so mailed, (iii) if delivered by International Federal Express (or comparable service), two (2) business days after so mailed, (iv) if delivered by facsimile, upon electric
confirmation of receipt and shall be delivered as addressed as follows: 
  

			
	 (a)
	 	 if to the Company, to:

		
	 	 	 The Sands Regent

	 	 	 345 North Arlington Avenue

	 	 	 Reno, Nevada 89501

	 	 	 Attention:     Rob Medeiros

	 	 	 Telephone:   (775) 348-2200

	 	 	 Telecopy:     (775) 348-6241

		
	 	 	 with a copy mailed to:

		
	 	 	 Latham & Watkins LLP

	 	 	 650 Town Center Drive, 20th Floor

	 	 	 Costa Mesa, California 92626

	 	 	 Attention:     Patrick T. Seaver, Esq.

	 	 	 Telephone:   (714) 755-8204

	 	 	 Telecopy:     (714) 755-8290

  
 (b) if to the
Investor, at its address on the signature page hereto, or at such other address or addresses as may have been furnished to the Company in writing. 
  

 16 

 8. Changes. This Agreement may not be modified or amended except pursuant to an instrument in writing signed by
the Company and the Investor. 
  
 9. Headings. The headings of the various
sections of this Agreement have been inserted for convenience of reference only and shall not be deemed to be part of this Agreement. 
  
 10. Severability. In case any provision contained in this Agreement should be invalid, illegal or unenforceable in any respect, the validity, legality and
enforceability of the remaining provisions contained herein shall not in any way be affected or impaired thereby. 
  
 11. Governing Law. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of Nevada without giving effect to the
principles of conflicts of law. 
  
 12. Counterparts. This Agreement may be
executed in two or more counterparts, each of which shall constitute an original, but all of which, when taken together, shall constitute but one instrument, and shall become effective when one or more counterparts have been signed by each party
hereto and delivered to the other parties. 
  
 13. Form 8-K. On the Closing
Date, the Company shall file a Form 8-K announcing the material terms of the transaction set forth herein and any other information which the Company considers material to purchasers and sellers of the Company’s Common Stock. 
  
 14. Reliance by Third Parties. This Agreement is intended for the benefit of (i) the
parties hereto and their respective successors and permitted assigns, and (ii) for the Placement Agent, as to those provisions in Section 3, 4 and 13, and any other covenants of the Company contained in this Agreement, and is not for the benefit of,
nor may any provisions hereof be enforced by, any other persons, except as otherwise set forth in Section 6.3(d). 
  
 15. Independent Nature of Investors’ Obligations and Rights. The obligations of each Investor under the Agreements are several and not joint with the
obligations of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under any Agreement. The decision of each Investor to purchase Securities pursuant to the Agreements has
been made by such Investor independently of any other Investor. Nothing contained herein or in any Agreement, and no action taken by any Investor pursuant thereto, shall be deemed to constitute the Investors as a partnership, an association, a joint
venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Agreement. Each Investor acknowledges that no
other Investor has acted as agent for such Investor in connection with making its investment hereunder and that no Investor will be acting as agent of such Investor in connection with monitoring its investment in the Securities or enforcing its
rights under the Agreements. Each Investor shall be entitled to independently protect and enforce its rights, including without limitation the rights arising out of the Agreements, and it shall not be necessary for any other Investor to be joined as
an additional party in any proceeding for such purpose. 
  

 17 

 EXHIBIT A 
  
 THE SANDS REGENT 
  
 STOCK CERTIFICATE QUESTIONNAIRE 
  
 Pursuant to Section 2 of the Agreement, please provide us with the following information: 
  

					
	 1.
	  	The exact name that your Shares are to be registered in (this is the name that will appear on your stock certificate(s)). You may use a nominee name if appropriate:	 	  

			
	 2.
	  	The relationship between the Investor and the registered holder listed in response to item 1 above:	 	  

			
	 3.
	  	The mailing address of the registered holder listed in response to item 1 above:	 	  

			
	 4.
	  	The Social Security Number or Tax Identification Number of the registered holder listed in the response to item 1 above:	 	  

  

 1 

 EXHIBIT B 
  
 THE SANDS REGENT 
  
 INVESTOR QUESTIONNAIRE 
  
 (all information will be treated confidentially) 
  
 To: The Sands Regent 
  
 This Investor Questionnaire (“Questionnaire”) must be completed by each potential investor in connection with the offer and sale of the
shares of the common stock, par value $.10 per share (the “Securities”), of The Sands Regent (the “Company”). The Securities are being offered and sold by the Company without registration under the Securities Act of
1933, as amended (the “Securities Act”), and the securities laws of certain states, in reliance on the exemptions contained in Section 4 of the Securities Act and on Regulation D promulgated thereunder and in reliance on similar
exemptions under applicable state laws. The Company must determine that a potential investor meets certain suitability requirements before offering or selling Securities to such investor. The purpose of this Questionnaire is to assure the Company
that each investor will meet the applicable suitability requirements. The information supplied by you will be used in determining whether you meet such criteria, and reliance upon the private offering exemption from registration is based in part on
the information herein supplied. 
  
 This Questionnaire does not
constitute an offer to sell or a solicitation of an offer to buy any security. Your answers will be kept strictly confidential. However, by signing this Questionnaire you will be authorizing the Company to provide a completed copy of this
Questionnaire to such parties as the Company deems appropriate in order to ensure that the offer and sale of the Securities will not result in a violation of the Securities Act or the securities laws of any state and that you otherwise satisfy the
suitability standards applicable to purchasers of the Securities. All potential investors must answer all applicable questions and complete, date and sign this Questionnaire. Please print or type your responses and attach additional sheets of paper
if necessary to complete your answers to any item. 
  
 A.
BACKGROUND INFORMATION 
  

							
	 Name:

	
	 Business Address:

	 	  	 (Number and Street)
	  	 
	
	  

	 (City)
	  	 (State)
	  	 (Zip Code)

	
	 Telephone Number:
(            )

	
	 Residence Address:

	 	  	 (Number and Street)
	  	 
	
	  

	 (City)
	  	 (State)
	  	 (Zip Code)

	
	 Telephone Number:
(            )

	
	 If an individual:

				
	 Age:

	  	 Citizenship:

	  	Where registered to vote:	  	  

	
	 If a corporation, partnership, limited liability company, trust or other entity:

	
	 Type of entity:

		
	 State of formation:

	  	Date of formation:

	
	 Social Security or Taxpayer Identification No.

				
	 Send all correspondence to (check one):             
	  	 Residence Address
  
	  	 	  	 Business Address

  

 1 

 B. STATUS AS ACCREDITED INVESTOR 
  
 The undersigned is an “accredited investor” as such term is defined in Regulation
D under the Securities Act, as at the time of the sale of the Shares the undersigned falls within one or more of the following categories (Please initial one or more, as applicable): 
  
              (1) a bank as defined in Section 3(a)(2) of the Securities
Act, or a savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity; a broker or dealer registered pursuant to Section 15 of the Securities
Exchange Act of 1934; an insurance company as defined in Section 2(13) of the Securities Act; an investment company registered under the Investment Company Act of 1940 or a business development company as defined in Section 2(a)(48) of that act; a
Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958; a plan established and maintained by a state, its political subdivisions, or any agency or
instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000; an employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974 if
the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets
in excess of $5,000,000 or, if a self-directed plan, with the investment decisions made solely by persons that are accredited investors;1 
  
              (2) a private business development company as defined in Section 202(a)(22) of the Investment Adviser Act of 1940; 
  
              (3) an
organization described in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended, corporation, Massachusetts or similar business trust, or partnership, not formed for the specific purpose of acquiring the Shares offered, with total
assets in excess of $5,000,000; 
  
              (4) a natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of such person’s purchase of the Shares
exceeds $1,000,000; 
  
              (5) a natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person’s spouse in
excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year; 
  
              (6) a trust, with total assets in excess of $5,000,000, not formed for the specific
purpose of acquiring the Shares offered, whose purchase is directed by a sophisticated person as described in Rule 506(b)(2)(ii) of Regulation D; and 
  
              (7) an entity in which all of the equity owners are accredited investors (as defined
above). 
  

	1	As used in this Questionnaire, the term “net worth” means the excess of total assets over total liabilities. In computing net worth for the purpose of
subsection (4), the principal residence of the investor must be valued at cost, including cost of improvements, or at recently appraised value by an institutional lender making a secured loan, net of encumbrances. In determining income, the investor
should add to the investor’s adjusted gross income any amounts attributable to tax exempt income received, losses claimed as a limited partner in any limited partnership, deductions claimed for depreciation, contributions to an IRA or KEOGH
retirement plan, alimony payments, and any amount by which income from long-term capital gains has been reduced in arriving at adjusted gross income. 

  

 B-2 

 C. REPRESENTATIONS 
  
 The undersigned hereby represents and warrants to the Company as follows: 
  
 1. Any purchase of the Securities would be solely for the account of the undersigned and not for the account of any
other person or with a view to any resale, fractionalization, division, or distribution thereof. 
  
 2. The information contained herein is complete and accurate and may be relied upon by the Company, and the undersigned will notify the Company
immediately of any material change in any of such information occurring prior to the closing, if any, with respect to the purchase of Securities by the undersigned or any co-purchaser. 
  
 3. There are no suits, pending litigation, or claims against the undersigned that could materially affect the net
worth of the undersigned as reported in this Questionnaire. 
  
 4. The undersigned acknowledges that there may occasionally be times when the Company, based on the advice of its counsel, determines that it must suspend the use of the Prospectus forming a part of the Registration Statement (as
such terms are defined in the Stock Purchase Agreement to which this Questionnaire is attached) until such time as an amendment to the Registration Statement has been filed by the Company and declared effective by the Securities and Exchange
Commission or until the Company has amended or supplemented such Prospectus. The undersigned is aware that, in such event, the Shares will not be subject to ready liquidation, and that any Securities purchased by the undersigned would have to be
held during such suspension. The overall commitment of the undersigned to investments which are not readily marketable is not excessive in view of the undersigned’s net worth and financial circumstances, and any purchase of the Securities will
not cause such commitment to become excessive. The undersigned is able to bear the economic risk of an investment in the Securities. 
  
 5. The undersigned has carefully considered the potential risks relating to the Company and a purchase of the Securities, and fully understands
that the Securities are speculative investments which involve a high degree of risk of loss of the undersigned’s entire investment. Among others, the undersigned has carefully considered each of the risks described under the headings “Risk
Factors” in the Company’s Annual Report on Form 10-K for the year ended June 30, 2004. 
  

 B-3 

 IN WITNESS WHEREOF, the undersigned has executed this Questionnaire this
             day of November, 2004, and declares under oath that it is truthful and correct. 
  

			
	 Print Name

		
	 By:
	 	  

	 Signature

		
	 Title:
	 	  

	 	 	 (required for any purchaser that is a
 corporation,
partnership, trust or other entity)

  

 B-4 

 EXHIBIT C 
  
 THE SANDS REGENT 
 CERTIFICATE OF SUBSEQUENT SALE 

					
	  

	 	 	 	 
	  

	 	 	 	 
	  

	 	 	 	 
	  

	 	 	 	 

  

	 	RE:	Sale of Warrant and/or Shares of Common Stock of The Sands Regent (the “Company”) pursuant to the Company’s Prospectus dated
                , 200     (the “Prospectus”) 

  
 Dear Sir/Madam: 
  
 The undersigned hereby certifies, in connection with the sale of (i) a Warrant to purchase Common Stock of the Company and/or (ii) shares of Common Stock
of the Company included in the table of Selling Stockholders in the Prospectus, that the undersigned has sold the Warrant or shares pursuant to the Prospectus and in a manner described under the caption “Plan of Distribution” in the
Prospectus and that such sale complies with all applicable securities laws, including, without limitation, the Prospectus delivery requirements of the Securities Act of 1933, as amended. 
  

	
	 Selling Stockholder (the beneficial owner):

	 Record Holder (e.g., if held in name of nominee):

	 Restricted Stock Certificate No.(s):

	 Number of Shares Sold:

	 Warrant Sold:

	 Date of Sale:

  
 In the event that you
receive a stock certificate(s) representing more shares of Common Stock than have been sold by the undersigned, then you should return to the undersigned a newly issued certificate for such excess shares in the name of the Record Holder and BEARING
A RESTRICTIVE LEGEND. Further, you should place a stop transfer on your records with regard to such certificate. 
  

					
	 Dated:
	 	  

	 	 Very truly yours,

			
	 	 	 	 	 By:

			
	 	 	 	 	 Print Name:

			
	 	 	 	 	 Title:

			
	 cc:
	 	 Investor Relations
	 	 
	 	 	 The Sands Regent
	 	 
	 	 	  

	 	 
	 	 	  

	 	 
	 	 	  

	 	 

  

 1 

 EXHIBIT D 
  

FORM OF LEGAL OPINIONS 
  

 1 

 EXHIBIT E 
  

CERTIFICATE OF TRANSFER AGENT 
  

 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]